Interested parties may access a live webcast including a virtual slide presentation from the investor section of the VIA website, http://www.viapharmaceuticals.com. A replay will be archived on the VIA website for at least one week following the presentation.
About VIA Pharmaceuticals, Inc.
VIA Pharmaceuticals, Inc. is a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease. VIA is building a pipeline of small-molecule drugs that target a significant unmet medical need: reducing inflammation in the blood vessel wall, which is an underlying cause of atherosclerosis and its complications, including heart attack and stroke. The company's lead drug candidate, VIA-2291, is in multiple Phase 2 clinical studies in patients with cardiovascular disease. For more information, visit: http://www.viapharmaceuticals.com.
About Noble Financial
Noble Financial is a privately-held, full-service capital markets firm
driven by what is often overlooked by other firms -- uncovering the value
embedded in the orphaned, undiscovered or misunderstood company. The company
focuses on converting market inefficiencies into profit opportunities. Noble
Financial supports emerging companies through strategic advice, investment
banking, market-making, sales & trading, comprehensive equity research, and
the development of institutional support. Noble Financial's equity
conferences --
SOURCE VIA Pharmaceuticals, Inc.